MedPath

Effectiveness of Smartconsent in Improving Understanding of Informed Consent

Not Applicable
Completed
Conditions
Benign Prostatic Hyperplasia
Registration Number
NCT04856943
Lead Sponsor
Bioaraba Health Research Institute
Brief Summary

The general objective of the study is to assess whether the new smartconsent tool improves patients' understanding of the intervention to be performed, compared to standard practice.

A randomized clinical trial will be conducted in 50 patients who will undergo LASER PROSTATIC ENUCLEATION.

Detailed Description

Male patients aged between 50 and 70 years, belonging to the Hospital Universitario Araba who are going to undergo PROSTATIC LASER ENUCLEATION, and who attend urology consultation between December 2019 and December 2020, and who meet the inclusion criteria and none of the exclusion criteria.

Inclusion criteria:

* Patients willing to receive information via tablet.

* Patients who know how to and can read.

Exclusion criteria:

-Not applicable.

Main variable: score on the Multiple choice test questionnaire (designed specifically for each type of procedure, following the recommendations proposed by Kehoe, Jerard and Fathelrahman et al. and developed on the basis of the information that an informed consent should provide (1, 2), with 4 response options and only one correct answer. An average score will be calculated for each patient.

This test evaluates the comprehension of the information provided through the informed consent.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria

Not provided

Exclusion Criteria
  • Not applicable

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Score in the Multiple choice test questionnaireAt the recruitment moment

Specifically designed for each type of procedure, following the recommendations proposed by Kehoe, Jerard and Fathelrahman et al. and developed on the basis of the information to be provided in an informed consent form, with 4 response options and only one correct answer

Secondary Outcome Measures
NameTimeMethod
Ability to complete the informed consent formAt the recruitment moment

Without the need for additional information from the healthcare professional.

Satisfaction with the informed consent proccessAt the recruitment moment

based on three ad hoc designed items: Each item will be scored on a lipo Likert scale with 5 response options.

Overall satisfaction with the informed consent process,At the recruitment moment

Through a three-item test, developed ad hoc by a group of researchers to assess satisfaction in a study with similar characteristics to ours.

Time required to complete the informed consent process (MIN).At the recruitment moment

The Smartphone stopwatch of the researchers participating in the study will be used for this purpose

Score in the System Usability ScaleAt the recruitment moment

In the SMARTCONSENT group only. he average System Usability Scale score is 68. If your score is under 68, then there are probably serious problems with your website usability which you should address. If your score is above 68, then you can relax a little bit.

Trial Locations

Locations (2)

Imanol Merino

🇪🇸

Vitoria Gasteiz, Alava, Spain

Bioaraba Health Research Institute

🇪🇸

Vitoria-gasteiz, Alava, Spain

Imanol Merino
🇪🇸Vitoria Gasteiz, Alava, Spain
© Copyright 2025. All Rights Reserved by MedPath